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 1. ABSTRACT 
 
Three-dimensional scaffolds play important roles in scaffold guided tissue engineering 
because they provide critical functions as extra-cellular matrices onto which cells can 
attach, grow, and form new tissues. To design scaffolds for load bearing tissue 
replacement, researchers often needs to address multiple biological, mechanical and 
geometrical design constraints. Therefore a novel fabrication system, Precision Extrusion 
Deposition (PED), has been developed allowing for the precise control of the scaffold 
external and internal geometry, porosity, pore size and interconnectivity. The system 
consists of a screw driven heated mini-extruder mounted on a 3-axis positioning system. 
This allows for bulk agglomerates of thermoplastic material to be fabricated into 
structures of a specified geometry.  
A computer-aided tissue engineering approach (CATE), combined with the PED process, 
Polycaprolactone and composite Polycaprolactone/ Hydroxyapatite scaffolds for bone 
tissue engineering applications were fabricated. Characterizations through SEM, Micro-
CT and mechanical testing demonstrate the viability of the PED process. The results 
show good mechanical property, structural integrity, controlled pore size, and pore 
interconnectivity. The biological compatibility of the fabricated scaffolds was proved 
through both In-vitro cell culture and In-vivo nude mice studies.  
This major accomplishments reported in this thesis are:  
• The development of a novel fabrication technology to manufacture load 
bearing tissue scaffolds with controlled and reproducible micro-
architecture 
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• Demonstrated the compatibility of the structures, through a variety of 
characterization techniques, with biological systems and the potential in 
Tissue Engineering applications 
 
The PED technique offers a unique opportunity to study the influence of the micro-
architecture upon cell proliferation and ECM generation allowing for the needed 
structural integrity, strength, and transport properties, for and an ideal micro-environment 
for cell and tissue in-growth and healing . 
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2. BACKGROUND 
 
Musculoskeletal trauma, pathological degradation, or congenital deformation often results in 
surgical bone reconstruction or replacement. Currently, the preferred method or repair is to 
surgically replace the defective tissue with a autolougus bone graft. The graft assists the body 
natural ability to heal the defect. The autograft is a section of bone taken from patient’s own 
body. The harvest site is damaged by the remove of the graft, which often leads to donor site 
morbidity, and the amount of bone available for harvesting is often limited. Alternatively, 
allografts are taken from a cadaver. Rejection of the donar tissue is a risk due to the immune 
response of the body, and immune suppressants are often employed. This grafting method 
provides the defect site with structural stability and natural oseteogenic behavior . However, The 
resorption characteristics of grafts are often unpredictable an rejection is possible. [13,51,105] 
If it is determined that a graft is insufficient to repair the damaged or defective tissue, a prosthetic 
or synthetic implant is often used. These are designed to replace and take over the function of the 
defective tissue. Often for muckuloskelatal replacement, metallic implants, such as titanium, steel 
and cobalt chromium alloys are used. These materials are mechanically strong and are known to 
cause little or no toxic effects. However implant failure through fatigue and corrosion does occur. 
In addition the dissimilarities in the mechanical properties often results in the weakening of the 
surrounding tissues. Due to these problems and the limited supply of graft material, research has 
been conducted to develop synthetic alternatives to regenerate the tissue rather than to replace. 
[13,65]   
The synthetic grafts are often made of bioresorbable materials that can degrade into harmless by-
products and then be resorbed by the body. By controlling the properties and characteristics, these 
implants can stimulate or assist in tissue regeneration. These implants are capable of serving as a 
scaffold for bone ingrowths and can eventually be completely replaced by natural tissue. [28,105] 
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2.1. Bone tissue engineering  
 
The field of tissue engineering seeks to regenerate or replace organic tissues and organs. Scaffold 
based tissue engineering endeavors to provide a biodegradeable porous matrix which mimics the 
body’s own extra-cellular matrix, onto which cells can attach, multiply, migrate and function. In 
one approach a patients’ cells are seeded onto the synthetic scaffold and cultured in-vivo. The 
scaffold is then implanted in place of the diseased or defect area.. Over time, the synthetic matrix 
resorbs into the body and the cell produce their own natural extra-cellular matrix(ECM) 
eventually becoming indistinguishable from the normal healthy tissue.[12,13,18]. 
For the regeneration of bone the synthetic matrix should incorporate factors that are 
osteoconductive. Bone tissue itself has a highly porous structure that is for the most part a 
composite of collage and hydroxyapatite. It is this mineral content of the tissue that is the 
influential factor in determining the load bearing capacity of the bone. Regions of the skeletal 
system that often see very little loading, such as the cranium, have a different, usually less dense, 
pore structure and minerals density to that of bone in a region that is subject to high loading, such 
as the femur. Looking at the microstructure of an individual bone, we see a heterogeneous 
structure, giving it an anisotropic characteristic, making it strong in compressive strength but 
relatively weak in the shear. Bone is also a dynamic material that is capable of self repair; it 
changes with age and is influence by the loading environment.  Bone tissue engineering makes 
use of this repair or remodeling process to regenerate the tissue.  The scaffold often has specially 
designed porous structure made of highly biocompatible ceramics, polymers or natural materials 
such as collagen, capable of handling the loading environment.  Often BMPs are incorporated, 
releasing them at certain rate, capability of osteoconduction and in supporting ingrowth of 
capillaries and cells . The scaffold provides a supportive matrix and appropriate environment for 
the bone cells to survive, proliferate, differentiate to form new bone tissue. Over time, the 
scaffold degrades at a controllable rate compatible with the tissue ingrowth rate, resulting in 
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natural bone tissue in the place of the scaffold[13,27,67].  
 The bone scaffold should be biocompatible and osteoconductive, contain osteoinductive factors 
to enhance new bone ingrowth.  The design characteristics include: 
• Biocompatibility: The scaffold material must be biocompatible and promote cell 
adhesion and growth. It should be biodegradable with byproducts that have no toxic 
effect.  
• Internal porous architecture:  The pore volume should be sufficient to allow cell 
seeding , tissue ingrowth, and transport of nutrient. In literature a porosity greater 
than 60% is desirable with a pore size greater than 200 microns.   
• Mechanical properties. The scaffold provides mechanical support during the 
reconstruction process, thus the scaffold has to have sufficient mechanical integrity.  
The mechanical strength should be similar to the type of bone they are replacing in 
on order to be functionally relavant. The compressive module is in the range of 0.01 
to 2.0 GPa for Trabecular bone, and 14 to 18 GPa for cortical bone.  
2.2. Existing fabrication techniques  
 
    Several fabrication technologies have been studied to fabricate biodegradable and 
bioresorbable materials into 3-D scaffold with high porosity.  
Particulate leaching 
On method of particle leaching involves scaffold of poly(caprolactone) and poly(D,L-
lactic-co-glycolic acid)  that were blended with hydroxyapatite to form scaffold for bone 
tissue engineering. The biopolymer is dissolved in chloroform. NaCl and HA particles are 
suspended into the solution. The solvent evaporates leaving a porous composite material. 
After evaporation of the solvent the scaffold is immersed in water for 24hrs to dissolve 
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the NaCl and then dried. While this process can produce highly porous scaffolds, the 
thickness is limited to approximately 3 mm [60,102] 
Phase separation 
This technique involves the dissolution of a polymer in a solvent at low temperatures. In 
one example, PLLA or PLGA is mixed dissolved into dioxane. Subsequently HA 
particles are added to the solution. Through a rapid temperature change where the 
solution is put into a freezer, the solvent turns to a solid. A solid liquid separation takes 
place. The sample is then immersed into liquid nitrogen and then freeze dried. The 
solvent evaporates during this process leaving a porous scaffold. The result was scaffold 
of a porosity greater than 90%. [102,110] 
Electrospinning 
Electrospinning is a widely used technique to create fibrous mesh with structural filament 
at a nano-scale allowing for high surface areas and porosity. PLGA has been spun into 
non-woven fibers with an average diameter of 760nm. A polymer solvent solution is 
loaded into a syringe. A high voltage is generated at the needle tip, (the negative pole).   
A aluminum collection plate, (positive pole), is place 5cm from the tip. The mixture is 
pulled from the needle, and as the fibers are collected the solvent evaporates.  
Gas foaming: 
In this method, gas is dissolved in a polymer under high pressure and room temperature and then 
expanded to form bubbles by releasing the pressure. Scaffolds with porosity of 93% and pore 
sizes of roughly 100μm have been reported [101]. 
 In the above methods, highly porous scaffolds are successfully created. While a specified 
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pore size or porosity can be synthesized, they are random. More over in many cases an 
interconnected network cannot be assured. If a controlled pore gradient is desired, these processes 
would not be able to achieve the desired design. Most of the above-mentioned processes involve 
organic solvent , the residue of which may be harmful. In addition, most of the scaffolds made 
through these processes have relatively low mechanical strength, which may lead to problems 
with implant failure.  
2.3. Solid Freeform Fabrication for Bone Scaffold Manufacturing 
 
Solid freeform fabrication technologies (SFF), is a new manufacturing technology that are 
capable of producing complex freeform parts directly from a computer aided design (CAD) 
model of an object. The models can be designed or obtained through reverse engineering to 
reconstruct three dimension models from the data of CT or MRI data . The model is then 
transferred into STL file, using sets of triangles to represent the model surface. The STL model is 
sliced layer by layer with certain interval to get the profile of every section; the profiles of every 
section are further segregated into series of scanning lines or dots; based on this, numerical 
control codes are generated to control the machine. Reversely, the machine stacks material layer 
by layer to construct  a 3-D physical parts. [36,39,102] 
Solid Freeform Fabrication technology possesses several unique advantages that make it a 
powerful manufacturing tool for three dimension bone scaffolds. Firstly the three-dimension 
CAD model of the bone tissue can be reconstructed precisely by reverse engineering software 
based on the data of computed topography (CT) and magnetic resonance imaging (MRI) system. 
The SFF machine can subsequently make the scaffold with any complex geometry in very high 
accuracy Secondly, SFF technology makes parts in an additive fashion through layer-by-layer 
process, so the internal structure of the porous scaffold can be controlled directly and precisely to 
meet any special requirements. Heterogeneous gradient structures matching the biological 
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requirements through computer aided design; the interconnectivity of the pores can be achieved. 
The current medical applications of SFF technology ranged from design and building of medical 
implants and devices to preoperative plan tools for surgeons. [79,86,88,102] 
 
Selective Laser Sintering 
 
Figure 1: Selective Laser Sintering 
 
 
Selective laser sintering (SLS) uses finely ground powders that are sintered by a laser to 
generate parts. A built piston raises and lowers the material within the feed bin while a 
spreading apparatus move a layer of material onto the build platform. A CO2 laser then 
sinters the powder together. The built platform lowers by one layer increment and the 
feed chamber raised by the say amount, and the process is repeated. Any excess powder 
is moved to an excess bin. The build chamber is also heated to just below the melting 
point of the material to reduce the energy needed by the laser to sinter the materials. Once 
the part is completed the part is removed and any excess powder is blown off of the part. 
Unlike some other SFF process, SLS needs no support structures because the un-sintered 
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powder on the build platform acts as a support. 
At the University of Michigan PCL scaffold were fabricated by creating fine particles of 
PCL. Another group at the Nanyang Technological University successfully used this 
technique to fabricate samples of a PEEK/HA composite and a polyvinyl 
alcohol/hydroxyapatite composite. In the University of Texas at San Antonio, researchers 
used Selective Laser Sintering process (SLS) to make customer artificial limb components. 
While SLS is capable precise microstructure detail, excess powder can be difficult to remove 
leading to material trapped within the part. [14,24,41,98] 
 
Steriolithography (SLA) 
SLA is similar in principle to SLS. It involves a liquid photo-curable material solidified by a 
ultraviolet laser. Since this method involves a liquid material rather than sold powder material, a 
support structure is required. This prevents overhanging structures or any unconnected features to 
fall to the bottom. In University of Toronto, Canada, researchers had fabricated porous calcium 
polyphosphate (CPC) implants using SLA process, and evaluated the in vitro degradation 
characteristics of the scaffold. In their research, fine CPC powder were added to an UV curable 
monomer at solid loading of 25%(vol), after the part had been made, it was sintered to remove the 
binder producing porous amorphous samples with average porosity of 27.7±2%, and further 
sintering produced crystalline samples with average porosity of 22.9±1.3%. The reliance on a UV 
curable momomer, with toxic byproducts, could limit its applications for tissue engineering. 
[103,107]. 
Fused Deposition Modeling (FDM) 
In National University of Singapore, efforts had been done to make three-dimensional scaffold of 
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bioresorbable polymer using FDM process (Fused Deposition Modeling). PCL was fed into a 
temperature controlled extrusion head where it is heated to a semi-liquid state, thin lines of fused 
polymer was extruded and deposited to form a three-dimensional part layer by layer. Parts with 
different lay-down pattern and various porosity as well as different pore geometry had been 
made. The porosity can reach as high as 75%[36]. 
3-D Printing 
3-D Printing process (3DP) is also reportedly used to fabricate three-dimensional 
scaffold. The process involves drop on demand technology where droplets of binder 
material are printed on a bed of powder particles. One study use polylactic-co-glycolic 
acid (PLGA) mix with salt particles and a organic solvent. The result was pore structures 
of 45–150 mm with 60% porosity. In other research, powders of PLA or PGA are mixed with 
NaCl particulates and hydroxyapatite powder if needed; the powder is then spread into a powder 
bed. A print-head nozzle is then used to deposit chloroform solvent over the powder layer; the 
chloroform acts as a binder by partially dissolving the polymer. After the part is finished, the 
remaining chloroform is removed by drying and the salt is leached out by immersion in water. 
The porosity can reach 95%, the pore size, controlled by the size of salt particles, is typically 
100μ. This process involves toxic solvent any yields scaffold of low mechanical strength. And as 
with other process powder can be trapped within the part. [48,49,103] 
 
2.4. Research objectives 
 
Based on the evident need for a new method of scaffold fabrication the research 
objectives are: 
1. To develop a novel manufacturing process for the fabrication of biomechanical 
designed and customized load bearing tissue scaffold and replacements   
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2. To investigate biophysical and biomechanical properties of the designed and 
fabricated tissue scaffolds 
3. To study the in vitro and in vivo biological responses of cells to the internal 
micro-architecture, surface topography and chemistry of tissue scaffolds 
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3. DEVELOPMENT OF PRECISION EXTRUSION DEPOSITION 
SYSTEM 
 
Solid Freeform Fabrication (SFF) is an evolution of Rapid Prototyping (RP) techniques 
where the part is built in layers. While most of the previous technologies focused on 
building prototypes, recent advances have opened the field to a wider range of materials, 
shifting the focus to the creation of an agile fabrication technology producing a final 
product directly. 
Among of various SFF techniques Fused Deposition Modeling (FDM) was selected 
because it allows for the fabrication of objects with a complex structure directly and does 
not incorporate toxic chemicals or processes. Furthermore this is a material additive 
process, meaning there is no loss of material by cutting or milling. This is important due 
to the fact that many biomaterials tend to be costly.  Parts are fabricated by stacking 
layers, each of which is produced using  an extruded “road” onto a substrate in a 
specifically designed pattern or raster. The raster is generated from the “slicing” of a 3-
dimensional solid models (Figure 2). The platform is lowered and subsequent layers are 
built directly on top of one another.  
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Figure 2: FDM [91] 
 
In order to extrude the material, it first must be liquefied in a heated chamber, 
therefore the build material must be thermoplastic.  The material, in filament form is 
guided into the chamber by two rollers that provide the necessary pressure to force 
the material through the nozzle. 
 While this method has its advantages, there are drawbacks that limit the range of 
materials available, namely the filament and feed roller process. FDM requires a 
precursor filament fabrication that can be time consuming and costly[7,91] (Figure 3). 
The filament also must be long and continuous thorough the build process, any 
breakage will result in the stopping of the system. Furthermore, with even slightly 
brittle materials, it has been observed that backpressure from the chamber can cause 
buckling and breakage of the filament [90-92]. 
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Figure 3: Filament fabrication [7] 
 
Figure 4: Filament Buckling [91] 
 
 
 Due to these limitations a unique system was developed based on the FDM 
process, with modifications that would broaden its application. The new set-up, called 
Precision Extruder Deposition (PED) and consisting of a screw extruder mounted on 
Pellets of ECG9+PZT
Filament
Heated chamber
Laser
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a high-precision positioning system (Figure 5), operates using with bulk material in 
granulated form. 
 
 
Figure 5: Precision Extrusion Deposition system 
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Figure 6: PED internal screw 
 
  
3.1.   System Specifications 
 
For accuracy, the new extruder has been mounted on a three axis high precision linear 
motor system, the 400XR series from Daedal division of Parker Inc. 
The position system has a high accuracy with resolution up to 10 μm, bidirectional 
repeatability of ±1.3 μm, maximum acceleration up to 20m/sec2. Square rails linear 
bearing, provide high load carrying capability, and smooth precise motion. High 
efficiency ball screw drive, which offer high throughput, efficiency, accuracy 
mm μμ 1810 ±÷±  and repeatability  ( mμ3.1± ). The encoders that offer direct positional 
feedback of the carriages location.Electromagnetic shaft brake on the vertical axis that 
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halts the carriage motion during a power loss. [21] 
The three positioning tables are connected to three Compumotor Gemini digital servo 
drives, which allow torque, velocity and encoder tracking modes. They are also equipped 
with digital notch filters that provide tools to eliminate mechanical resonance.  
The three drives are thus connected to one 6K4 Compumotor controller, which 
communicates to the computer through the serial port SR-232. With the use of the 6K 
Compumotor it is possible to write only one program to control position, speed, 
acceleration, deceleration etc. of the three axes at the same time. 
 
3.2. Extruder 
The extruded is a proprietary design by  Shinko Sellbic Co.  in Tokyo. It is based on the 
high volume manufacturing process where thermoplastic material is formed into producs 
like piping, tubing, and wire insulation to name a few. In the extrusion of plastics, bulk 
material in the form of small beads is fed from a hopper into the barrel of the extruder. 
The material enters a heated chamber and comes into contact with the screw. The rotating 
screw forces the bulk material forward . The material is heated to a desired temperature 
allowing for the viscosity to be sufficient for extrusion. Extra heat is contributed by the 
intense pressure and friction taking place inside the chamber. [78] 
For our system the heating chamber and screw are significantly shorter which will 
minimize the frictional heating, in addition the rotation speed of the screw is less than the 
typical extrusion process. The smaller size also allows for the mounting of the extruder 
vertically on the precision platform. 
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Figure 7: Extruder 
 
 
An addition control system , built by Shinko Sellbic Co.  in Tokyo, controls the heaters 
and the motor for the extruding screw (Figure 6) . Two copper heating elements are 
attached to the outside surface of the extruder. A voltage is applied across the copper to 
supply the heat. Two J-type thermocouples ( model HTK0221, Hakko Co. LTD, Japan) 
are connected to a proportional–integral–derivative controller (PID) which regulates the 
chamber temperature. The two thermocouples are at the entrance of the liquefier and at 
the exit .  
The rotational speed of the screw can be regulated either manually or through the 
interface of a digital device. To aid in the geometric consistency, the rotation speed of the 
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screw is proportional to the speed of the x-y axis velocities. [96] 
Worm-gear setmotor
Heating bands
Material housing
Nozzle tip
Material inlet
Servo Driver
Thermal couple
SRR
SRR
Temp Controller
Temp Controller
Motion 
controller
IPC
S
crew
 
Figure 8: PED control system diagram [96] 
 
The design of the nozzle tip controls the diameter size of the extrudate. Currently we 
have the six sizes available.  The smallest is 0.125 microns, followed by 0.1778 
microns then 0.254 microns, up to 0.508 microns.  The nozzles are made from 
aluminum. 
 
Figure 9: Nozzle 
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3.3. Motion control system  
 
The motion control system consists of three axes, X-Y-Z; each axis is actuated by one 
AC servo motor which is driven by servo driver; the three servo driver is controlled by 
6K4 servo/stepper controller which communicates with the computer through RS232 
serial communication port. The 6k4 servo/stepper controller has the capability of 
controlling 4 axes simultaneously, and also provides digital input/output function.  The 
position system has a high accuracy with resolution up to 10 μm, bidirectional 
repeatability of ±1.3 μm, maximum acceleration up to 20m/sec2. [21,96] 
6K
4 Servo/Stepper C
ontroller
Servo Driver Servo Motor Screw-Drive Actuator
Travel Limits
Power
Position feedback
coupler
Servo Driver Servo Motor Screw-Drive Actuator
Travel Limits
Power
Position feedback
coupler
Servo Driver Servo Motor Screw-Drive Actuator
Travel Limits
Power
Position feedback
coupler
RS232 to
Computer
Brake
 
Figure 10: Structure of the motion system [96] 
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3.4. Toolpath Definition 
 
Part design is achieved through two different systems of tool path generation. The 3 
axis linear motion system is controlled through the software Motion Planner (Parker, 
USA). This application allows for direct communication to both the 6k controller and 
the Gemini servos. Predefined programs with toolpath information can be uploaded 
through motion planner. However, in the case of complex geometries, like that of 
irregular anatomical structures, a separate application has been developed to generate 
the tool path information and interface with the Motion Planner system. This allows 
for the direct translation of 3D STL data into 2D sliced file format for fabrication. 
 
Figure 11: PED control system application 
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Figure 14: PED fabricated spiral 
 
In order to minimize this effect, it was determined that the rotation of the screw, 
responsible for the flow of material, would have to be proportionally controlled with the 
x-y axis velocities. This would mean that as the motion of the system along to tool path 
decelerated, so does the rotation of the screw, minimizing the agglomeration at the end. 
The proportional ratio can be adjusted to coordinate the positioning system and material 
dispensing system. Now we can have a consistent flow rate of material from the nozzle 
since the screw speed is dependent on the speed of the system. Additionally, the screw 
stops between each layer, preventing a buildup of material at the finish point of each 
layer. Figure 15 shows parts fabricated after the proportional control was added. There 
are no agglomerations and the exrudate or filament diameter appears consistent 
throughout the entirety of the part. 
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Figure 15: Improved PED Accuracy 
 
3.6. Conclusion 
 
A new solid free form fabrication technique, Precision Extrusion Deposition, was created. 
The system is capable of creating structures of thermoplastic material with precision that 
is comparable to other layered manufacturing techniques. The hardware component of the 
PED consists of an XYZ position system, a screw extruder, and a temperature control 
system. The software component consists of a data processing software and a system 
control software. The data processing software slices the STL files and generates the 
process toolpath. The system control software controls the material deposition according 
to the process toolpath to form a layered 3D object. 
The major advantage of the PED process over the conventional FDM process lies in that 
the scaffolding material can be directly deposited through PED process without involving 
filament preparation. This opens the door to a wider range of materials. Ceramic 
composite structure can be created without the limiting factor of the filament. 
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4. BIOMATERIALS FOR BONE TE 
 
The materials selected for the fabrication of tissue scaffold must meet some important 
criteria. 
 
1. Thermoplastic 
2. Biocompatible 
3. Biodegradable 
 
While these criteria are important, it does not necessarily translate into a successful 
scaffold allowing for favorable cell proliferation and growth of extra-cellular matrix 
(ECM).  
The first bio-polymer selected was: 
1. Polycaprolactone (PCL, Sigma Aldrich Inc, Milwaukee, Wisconsin) PCL is a 
semi-crystalline aliphatic polymer. It has a low glass transition temperature at -
60ºC, a melting temperature at 60ºC, with a high decomposition temperature Td of 
350ºC. The mechanical properties of PCL (Mw = 64,000) with a tensile strength of 
16MPa, tensile modulus of 400MPa, flexural modulus of 500MPa, elongation at 
yield of 7.0%, and elongation at break of 80% have been reported. The 
degradation rate is slow in comparison to other biopolymers. Due to its relatively 
high mechanical strength and good thermal stability it was chosen for the 
fabrication of scaffolds targeting hard tissue. [29,102] 
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2. Polycaprolactone/ Hydroxyapatite composite - Hydroxyapatite (HA) 
(Ca10(PO4)6(OH) , Clarkson Chromatography Products Inc, South Williamsport, 
PA) , a calcium phosphate ceramic, has been widely investigated for bone tissue 
engineering applications because of its chemical similarity to the mineral 
constituent of natural bone[32, 40]. It is both mechanically strong and 
osteoconductive. However, because of its brittle characteristic and material 
properties, it is often difficult to process. Therefore, by creating a composite of 
PCL, were PCL almost is a binder, the mechanical strength and bioactivity are 
improved over PCL alone. Furthermore the addition of HA to PCL will also affect 
the surface topography of the scaffold structure. Resulting a “rougher” region, 
where HA protrudes from the surface, which may affect cellular attachment. 
[11,13] 
 
PCL has been the subject of investigation as a scaffold material. A group in Singapore 
[37-39] successfully adapted the commercial FDM system to fabricate PCL scaffolds. 
Preliminary biological studies have shown favorable osseous integration in static cell 
culture into the PCL scaffold. While they were successful in creating scaffolds with a 
controlled repeatable microstructure the problem of filament fabrication and buckling, 
mentioned previously, limits the technique. Another group in Korea [47] were able to 
fabricate PCL scaffold using a UV photopolymerization technique. The PCL was 
dissolved in dixoane and mixed with a photoinitiator. The solution is then irradiated layer 
by layer to form the 3D structure. While this method allows for the creation of highly 
complex structures, the incorporation of a solvent, photoinitiator and photo radiation 
makes it undesirable for biological applications.  
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Since PCL is already used in the medical field as suture material [29] and its thermal 
stability it was chosen as the primary scaffold material for this research. 
Hydroxiapatite is widely used as a coating material for implants to promote tissue in 
growth allowing for improved integration [29, 101]. Since PCL has gained interest as a 
possible scaffold material, investigation into the biological response to a composite 
PCL/HA has been conducted [29,30,73,102].  One such study compared the cellular 
response to substrates of PCL and Composite PCL/HA material. The results showed a 
favorable cell matrix interaction for the composite material [73]. 
Since the PED system is capable of fabricating ceramic composite structures with 
favorable results over FDM [7] composite material of PCL/HA with 25% to 50% by 
weight HA, was investigated as a scaffold material. This will provide scaffolds with 
greater mechanical integrity, biocompatibility and hydrophilicity over PCL alone.  
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5.  POLYCAPROLACTONE (PCL) SCAFFOLDS FOR BONE 
TISSUE ENGINEERING 
 
The feasibility of using Precision Extruding Deposition (PED) to fabricate Poly-є-
Caprolactone (PCL) tissue scaffolds with designed micro-architectures was investigated. 
In contrast to the conventional FDM process that requires use of pre-cursor filaments, the 
PED process that is presented here directly extrudes scaffolding materials in a granulated 
form, thereby avoiding the need for filament preparation. The process can deposit the 
extruded material according to the designed micro-scale features allowing the 
manufacture of scaffolds with complex architectures. Micro-CT and Scanning Electron 
Microscopy (SEM) were used to characterize the morphologies and microstructures of 
the PED-fabricated scaffolds. An Instron 5800R mechanical testing device was used to 
determine mechanical properties of the scaffolds. Cell-scaffold interaction was studied 
using primary fetal bovine osteoblasts. The in vivo study was carried out using a nude 
mouse model to investigate the osteogenic properties of PED-fabricated PCL scaffolds. 
The constructs were implanted subcutaneously and the animals were sacrificed at pre-set 
time points. Following sacrifice, the scaffolds were explanted, examined radiologically, 
and examined microscopically. 
 
5.1.  Scaffold Design 
 
The design of the scaffold is based on the Unit Cell theory [86-88]. The design of a 
scaffold to replace or repair biological tissue, particularly that of hard tissue, is 
accomplished through certain key criteria. Characteristics such a bone density, porosity, 
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mechanical properties and pore size of native tissue can be retrieve from CT data [64,83] 
or existing literature on tissue mechanics [74]. Figure 16 shows the design process where 
information is taken from medical imaging and a hypothesized model for the scaffold is 
created. 
 
 
Figure 16: Unit Cell based scaffold design [88] 
 
 
The native physiological structure is randomized and complex [27]. In order to create a 
model within the bounds of current computer processing capabilities an equivalent 
hypothesized model is created rather that recreate the exact microstructure of the 
bone[84]. Each scaffold is made of unit cells with well characterized mechanical and 
transport properties. This enable a better understanding of the architecture and 
mechanical effect on the biological response since the scaffold are engineering within a 
specific criteria.  
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Base on previously reported research, the optimal pore size and porosity of a 
scaffold for bone tissue engineering are 200 microns – 500 microns and between 50% 
and 75% respectively[102]. Porosity of the PED fabricated scaffolds were calculated by 
imaging the top surface assuming that pore spacing is consistent throughout the entire 
height of the scaffold.  Figure 17 shows the model of the scaffold with 0°/90° layout 
pattern. Following fabrication the top surface of the scaffold was imaged using a 
microscope (Leica DM IL) at 4x and the pore size and extrudate width was measured 
using Image-J.   The porosity (φ) of the scaffolds was measured using following equation:  
 
Figure 17 :Scaffold Geometry 
 
2L is the length between the rodes which is half of the gap length (G) , α is the 
orientation angle and D is the diameter of the rode. The volume of the scaffold, V is ... 
V = 2L* D  
Volume of the rode is given by... 
 ⎟⎟⎠
⎞
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Note that the volume is calculated by taking a quarter of each rode in the scaffold since 
the repetitive unit consists of quarter rodes. So, Volume fraction of the rodes in the 
element is ... 
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We can further simplify the geometry by taking L1 = L2 = L. Then, 
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5.2. Scaffold Fabrication 
 
PCL (Sigma Aldrich Inc, Milwaukee, Wisconsin) in the form of pellets was used 
as the scaffold material. It has a low glass transition temperature of -60ºC, a melting 
temperature of approximately 58ºC-60ºC, and a high thermal stability. It has a high 
decomposition temperature of 350ºC. A Precision Extruding Deposition system 
developed at Drexel University was used for scaffold fabrication. The hardware 
component consists of an XYZ position system, a material extruder system, and a 
temperature control system. The software component consists of data processing software 
and system control software. The data processing software slices the STL files and 
generates the process toolpath. The system control software directs the material 
deposition according to the process toolpath to form a layered 3D object. The mini-
extruder system delivers the PCL in a fused form through the deposition nozzle. The 
pellet-formed PCL is then fused by a liquefier temperature provided by two heating 
bands and thermocouples. The PCL is finally extruded due to pressure created by a 
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rotating precision screw. The thermal couples were set to a temperature of 90 ºC to 
sufficiently reduce the viscosity of the polymer. 
To achieve deposition accuracy, the positioning system and the material mini-
extruder were synchronized. The material deposition roads (of both contouring and raster 
filing) consist of  a series of line segments, so the extruder movement is composed of a 
series of 2D linear interpolations upon which a simultaneous proportional signal to the 
XY position is extracted. The signal was used to drive the rotating motor of the material 
extruder. The proportional ratio can be adjusted to coordinate the positioning system and 
material dispensing system according to its controlled movement, speed, and material 
extrusion flow rate. The design scaffold CAD model was first converted into STL format, 
and then sliced using a slice pattern stored in the pattern library for toolpath generation. 
Each layer was then filled with the designed scaffold pattern to generate a toolpath file. 
The strands of PCL were extruded with a layer pattern of a 0°/ 90° orientation to create 
the porous structure. The in-house developed system control software provides functions 
for 3D part visualization, machine and process setup, testing, and real-time monitoring 
during the fabrication process. 
 
Figure 18: Fabricated Scaffold 
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Figure 19: Fabricated Scaffold 
 
5.3.  Morphological SEM Study 
 
An FEI/Philips XL-30 Field Emission Environmental Scanning Electron 
Microscope was used to evaluate the micro-structural form and internal morphology of 
the PED-fabricated scaffolds. These SEM images were taken by using beam intensity of 
20 kV and gaseous secondary electron detectors set at 1.3 Torr. The samples imaged were 
that of 65% porosity with 350um pores. In addition samples were sectioned by first 
freezing them in liquid nitrogen then cutting the scaffold with a straight razor. This 
allows for the visualization of the internal structure. Since the fabrication process does 
not involve a filler material it is necessary to visualize the internal structure there by 
determining if in fact the scaffold is porous thought. We can see that in Figure 20a the 
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pores continue through the depth of the scaffold.  Figure 20b&c shows the uniformity if 
the pore shape and size of the top surface of a PCL scaffold . 
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Figure 20: Scanning electron microscope images of scaffold showing 0°/90° layout 
pattern. Figure A and B represent lower and higher magnifications respectively. Figure C 
shows an unmagnified image of the scaffold 
 
The gaps, struts, and internal pore connectivity, as observed under SEM, demonstrate use 
of the PED process to fabricate PCL scaffolds at the micro-scale level. The SEM images 
clearly demonstrate that the PED-fabricated micro-architecture of the scaffolds via a 
0°/90° layered pattern . 
 
5.4.  Microstructure Analysis and 3D Reconstruction by Micro-CT 
 
Further structural analysis was conducted through X-ray Microtomography 
(micro-CT). [65] Three samples of three different architectures were scanned. All three 
types were fabricated with a nozzle creating a 200 micron filament. The pore size was the 
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variation being 200 microns, 300 microns, and 450 microns respectively. A SkyScan 
(Kontich, Belgium) 1172 micro-CT desktop scanner was used to scan the internal 
architecture of the scaffold.  The micro-CT was set at 19.1 micron resolution. The sample 
is placed within the Skyscan system atop a rotational stage (Figure 21). The source 
transmits x-rays thought the sample and is collected at the detector. Since the resultant 
data is a series of images collected on a rotational axis, an initial reconstruction is 
necessary to convert to the traditional x-y coordinate plane that is recognized my most 3D 
reconstruction software.   The program Nrecon (Skyscan, BE) was used to do the initial 
conversion.  
 
Figure 21: Skyscan Micro-CT System 
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Figure 22: Raw Micro-CT data viewed through Nrecon 
 
 The output format for each sample was approximately 500 serial 1024x1024 
bitmap images. These sliced images were analyzed in SkyScan’s CTAN software. The 
images are mapped as gray values that correspond to the radiodensity of the sample. The 
user, within the CTAN software, determines the gray value range that corresponds to the 
material that the user wishes to isolate. In this case the two materials were air and PCL. A 
subsequent conversion was conducted converting the gray value images into black and 
white. From that data the volume fraction and surface per unit volume were determined 
using 3D analysis. 3D reconstruction into an STL model was performed using Mimics 
software (Materialise, Leuven, Belgium). Sixty-two sequential pixel images were 
cropped from the serial images from the center of each sample. These serial core images 
were reconstructed into 3D volumetric models after importing them into Mimics.  
Micro-CT enables 3D characterization of PED-fabricated PCL scaffolds. Both 2D 
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and 3D analyses of porous core regions of the sample scaffolds were performed. A 3D 
reconstructed model using Mimics software is displayed in Figure 23. 
 
Figure 23: 3D Reconstructed PCL scaffold from Micro-CT data 
 
 Three PCL scaffolds reconstructed using the CTAN were analyzed for their 
porosity, and structural thickness. The porosity data can be found in Table 1. These 
results show little variation between samples for type 2 and 3, illustrating the 
repeatability of the process. However, we do see large deviation of type 1 which 
represents the smallest pore size fabricated. It is possible that as the gap between 
filaments get smaller, the accuracy of the system decreases. The structural thickness 
distribution was also calculated through the CTAN software. The target thickness is the 
filament thickness of 200 microns. In Figure 25 we can see that the values can range from 
100 to 300 microns. This is mostly due to the fact that the algorithm does not account for 
the cylindrical geometry of the filaments and the edge detail of the scaffold. However we 
 
 
40 
 
do see that the mean value is approximately 200 microns.  
 
Porosity 
 Type 1 Type 2 Type 3 
Sample1 (orange) 43.976 60.297 65.198 
Sample2 (green) 51.257 61.686 63.783 
Sample3 (blue) 39.370 60.123 65.187 
Average 44.868 60.702 64.723 
Standard Dev. 5.994 0.856 0.814 
 
Table 1: Scaffold porosity 
 
 
 
Figure 24: Pore Size Distribution 
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Figure 25: Structural thickness calculated from Micro-CT data 
 
5.5.  Mechanical Properties of Scaffolds  
 
An Instron 5800R machine was used to evaluate the compressive properties of 
PED-fabricated scaffolds. The samples were sandwiched between compression plates 
tested at a speed of 0.1 mm/minute. The initial strain rate was adjusted to 10% per 
minute, without any load before initiating compression testing. Standard solid 
compression platens were used for testing. Stress-Strain data were computed from Load-
Structural Thickness
0
10
20
30
40
50
60
70
80
34.53 - <103.60 um 103.60 - <172.67 um 172.67 - <241.74 um 241.74 - <310.81 um 310.83 - <587
Thickness
P
er
ce
nt type 1
type 2
type3
 
 
42 
 
Displacement measurements. The compressive modulus was determined based on the 
slope of the Stress-Strain curve in the elastic region, and the compressive strength was 
reported at 10% strain. The data was corrected on the strain axis to a value of 
approximately 0.025 for measuring the compressive modulus of the scaffold. The 
stiffness of the machine was included to decrease machine error. For comparative 
purposes, non-porous bulk samples of the overall equivalent dimension were fabricated 
using the PED system and evaluated in the same manner.   
Three specimens were tested under compression to a limit of specific compressive 
displacements. These PCL specimens were measured for their dimensions for accurate 
area calculations. The scaffolds were cylindrically shaped with minute irregularities on 
the circumference wall due to specimen processing. The average data is plotted in Figure 
26.  
 
 
Figure 26: Compressive properties of PCL scaffolds 
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The compressive modulus of scaffolds was found to be 59 MPa with a standard deviation 
of ±1.3 MPa. The compressive strength of the scaffolds were measured to be 5.3 MPa 
with a standard deviation of  ±0.103 MPa. By comparison, the fabricated non-porous 
samples had a compressive modulus of 109 MPa with a standard deviation of ±2.3 MPa. 
5.6. In vitro Cytotoxicty Evaluation of the PED Process 
 
It was important to evaluate the possibility of any cytotoxic effect of the fabrication 
process on the PCL scaffolds.  The rotation of the screw, while at a relatively slow speed, 
may induce frictional heating[77].  This additional heat may cause degradation of the 
material, the byproducts of which may induce adverse cytotoxic effects. A 10 day study 
was conducted on scaffolds of 65% porosity and with a pore size of 500 microns together 
with a control sample of cells seed at the bottom of a polystyrene well plate. The viability 
was measured over the 10 day period to assess viability of the process for biological 
applications with PCL. [72] 
The cell type was 7f2 osteoblasts. Alamar Blue assay, a fluorometric indicator of cell 
metabolic activity, was performed to determine cell viability. They were washed with 
PBS after aspirating the medium. They were then re-fed with 1.8 ml of media and 0.2 ml 
of the Alamar Blue dye and allowed to incubate for 4 hours. The resulting 2 ml solution 
was removed from the sample and the fluorescence was measured at room temperature 
on a plate reader (GENios, TECAN, Durham, NC) using excitation and emission 
wavelengths of 520 nm and 590 nm, respectively. We see that the cells continue to 
proliferate over the entire 10 day culture period. This is an indication that the fabrication 
process has no immediate cytotoxic effect. 
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Figure 27: Cell Viability over 10 days 
 
At the end of 10 days the scaffold were evaluated using a Live/Dead assay (Molecular 
Probes) and Hoechst 33258 (Sigma-Aldrich). The Live/Dead dye consists of calcein AM 
and ethidium homodimer (EthD-1) which react to membrane integrity and cytoplasmic 
esterases. Live cells appear green and dead appear red under the florescent microscope. 
Hoechst 33258  bind to the DNA of the cell and is visible under a florescent microscope, 
thereby making the nucleus visible. As we can see in Figure 28 and Figure 29, the live 
cells greatly outnumber the dead cell on the top surface of the scaffold. Figure 30 shows 
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and soaked in 2 ml of medium for 1 hour. Approximately 1.5 x 106 cells were seeded 
onto each scaffold. The cell scaffold constructs were maintained in culture for 21 days.  
 
5.7.1. Cell Viability  
 
Alamar Blue assay, a fluorometric indicator of cell metabolic activity, was performed to 
determine cell viability. The cell scaffold constructs were removed from the culture 
plates on days 3, 7, 11, 14, and 21. They were washed with PBS after aspirating the 
medium. They were then re-fed with 1.8 ml of media and 0.2 ml of the Alamar Blue dye 
and allowed to incubate for 4 hours. The resulting 2 ml solution was removed from the 
sample and the fluorescence was measured at room temperature on a plate reader 
(GENios, TECAN, Durham, NC) using excitation and emission wavelengths of 520 nm 
and 590 nm, respectively. 
The cells showed increased metabolic activity over time until day 11, thus 
representing an active proliferation period. Figure 31 shows the results of the Alamar 
Blue assay.  
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Figure 31: Osteoblast viability measured by Alamar Blue cell metabolic assay. 
 
The data is presented as the average of the 4 samples ± standard deviation. There was a 
statistically significant difference (p <0.05) in the cell metabolic activity over the cultured 
time. A slight decline was experienced between day 11 and 14. The decline in cell 
metabolic activity may be attributed to the inability of the Alamar Blue dye to react with 
cells trapped within the mineralization matrix after day 11 and/or due to slowing of cell 
metabolic activity as they migrate through the depths of the scaffold where nutrients are 
not as readily available. 
 
5.7.2. Alkaline Phosphatase Activity  
 
 Samples were removed from the medium and washed twice with a buffer solution 
on days 7, 14, and 21. The scaffolds were then submerged into 1 ml of 1% Triton x100 
solution for cell lysis. They were then centrifuged and the supernatant was used to 
calculate alkaline phosphatase (ALP) activity by the p-nitro phenyl phosphate (p-NPP) 
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method. Alkaline phosphatase catalyzes the cleavage of p-NPP to give p-Nitrophenol and 
orthophosphate which develops a yellow color in the presence of a base. A 0.5 ml sample 
of supernatant and 0.5 ml of diluted p-NPP (100μl of p-NPP concentrate per 2 ml of 100 
mM sodium bicarbonate/carbonate buffer, pH 10) were mixed and incubated for 45 mins. 
The absorbance of this mixture was read at 405 nm. The absorbance was converted to the 
units of alkaline phosphatase per liter. 
As seen from Figure 32, an up-regulation of alkaline phosphatase activity throughout the 
cultured time was observed, with the greatest increase within the first 14 days.  
 
Figure 32: Alkaline Phosphatase activity of osteoblasts cultured on PCL scaffolds 
 
 
5.7.3. Calcium Production 
 
Calcium levels were measured in the cell-scaffold constructs with a Calcium Test 
Kit (Stanbio Laboratories, Boerne, TX). The manufacturer’s protocols were followed on 
days 7, 14, and 21. The assay is based on the o-cresolphthalin complexone method which 
develops a purple color in the presence of calcium. The cell lysate was prepared using 0.5 
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ml Triton X-100 and 0.5 ml trichloroacetic acid. The samples were incubated for 60 mins 
and centrifuged. The supernatant was used to calculate the calcium levels. 0.01 ml of 
supernatant, 0.5 ml color reagent (o-cresolphthalin complexone), and 0.5 ml base reagent 
(2-amino, 2-methyl, 1-propanol) were mixed and incubated for 10 mins. The absorbance 
was read at 550 nm. The amount of calcium production was calculated from the standard 
curve. 
Mineralization of bone formed on the scaffolds was measured by calculating the amount 
of calcium produced by cells on days 7, 14, and 21. A steady increase in the amount of 
calcium produced by cells throughout the cultured time was observed (Figure 33).  
 
Figure 33: : Calcium production by osteoblasts seeded on PCL scaffolds 
 
Both ALP as well as calcium activities were measured from 4 samples. 
Statistically significant differences (P <0.05) in both the activities were observed over the 
cultured period. 
 
5.7.4. Cell Morphology by SEM 
 
The cell-scaffold constructs were removed from the culture media on days 14 and 
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21. They were washed twice with 1x PBS and then fixed with 4% glutaraldehyde for 2 
hrs. The constructs were then subjected to serial dilutions of ethanol (20%, 50%, 70%, 
90%, 100%), with each step exposure of 10 minutes for dehydration. The constructs were 
then refrigerated overnight at 4°C. The scaffolds were then coated with platinum and 
observed under SEM. 
The morphology and extent of mineralization on the PCL surfaces were assessed using 
SEM on days 14 and 21. The SEM images show mineralization of the scaffold by day 14 
(Figure 34A) and the entire scaffolds were covered by mineralized matrix by day 21 
(Figure 34B).  
 
 
Figure 34: Scanning electron microscopy images showing mineralized matrix produced 
by osteoblasts cultured on PCL scaffolds on day 14 (A) and day 21 (B). 
 
 
5.8.  In vivo Osteogenesis Study 
 
The review, and oversight of the in vivo osteogenesis study protocol and the 
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research specified by the protocol was conducted at The Department of Orthopaedic 
Surgery at The Medical University of South Carolina.  Fetal bovine osteoblast cells (5 x 
106 cells/implant) were cultured, mixed homogeneously in media, and seeded directly 
onto the external top surface of the PCL scaffolds using a Pasteur pipet. The environment 
for pre-implantation cell attachment included incubation in culture media at 37°C and 5% 
CO2. Samples of 2.5 x 8 mm cell-scaffold constructs were implanted into the 
subcutaneous tissue of 5-week old nude mice. An in vivo osteogenesis study was carried 
out on 12 animals. Four animals per study period were sacrificed at 4, 6, and 8 weeks 
post-operatively. Specifically, four implants were explanted for each study period (i.e., 
four at week 4, four at week 8, and four at week 12). After each study period, implants 
were removed and micro-CT scanning was taken on the specimens. The explants were 
fixed in 10% formalin for one day. They were then dehydrated in a series of ethanol 
dilutions (70%, 95%, and 100%), exposed to xylene, and embedded in paraffin. Five 
micron thick sections were made and stained with haematoxylin and eosin (H&E) 
staining solution. Each section was evaluated histologically and with micro-CT scanning 
to identify areas of osseous ingrowth.   
 The calcium deposition indicating osseous ingrowth was seen in the radiographic 
images (Figure 35A). Bright white areas indicating osteogenesis became apparent first in 
the 6-week group (Figure 35B).  
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Figure 35: Radiographic images of the PCL scaffolds explanted after 4 (A), 6 (B) and 8 
(C) weeks. 
 
These areas became more pronounced at the 8-week time period (Figure 35C). Figure 36 
shows the sections of osseous ingrowth, microscopically.  
 
 
Figure 36: Histological images (10x magnification) of the PCL scaffolds explanted after 
4 (A), 6 (B), and 8 (C) weeks indicate areas of bone matrix 
 
After using H&E staining procedures, the areas of bone growth could be differentiated 
from the surrounding tissues. The areas of bone matrix (dark pink) were surrounded by 
osteocytes (i.e., smaller purple regions surrounding the dark pink masses). These areas 
became more numerous and pronounced at the 8-week time period. Also, the bone matrix 
appeared to have become more complete in these sections (Figure 37).  
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Figure 37: Higher magnification (45x) histology image of the PCL scaffold explanted 
after 8 weeks. Arrow points to bone matrix within circled area. 
 
Micro-CT was carried out on the constructs explanted after 8 weeks. The image analysis 
was carried out to visualize the areas of osseous ingrowth. Figure 38 shows that the bone 
ingrowth permeates the scaffold. 
 
 
Figure 38: Micro-CT 3D reconstruction of the scaffold after 8 weeks of in vivo study. 
The top (A) and side (B) 3D views of the scaffold indicating areas of osseous ingrowth. 
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5.9.  Discussion 
 
Precision Extruding Deposition (PED) freeform fabrication of PCL scaffolds was 
tested using SEM, micro-CT, and biological assays to characterize the morphology, 
internal geometry, mechanical properties, and biological compatibility of these scaffolds. 
The results demonstrate the capability of PED fabrication to manufacture PCL scaffolds 
with controlled microstructure and strut size features of 345.35μm ± 5.90 μm. The 
scaffolds were 65% porous with 100% interconnectivity.  
Since this process directly fabricates scaffolds using a pore geometry design to 
direct layer by layer deposition without involving the material preparation and indirect 
casting, new opportunities for complex scaffold fabrication is created. Micro-CT 
characterization was found to be an effective tool for nondestructive evaluation of PCL 
scaffolds. The use of 2D analysis and 3D reconstruction software allows the examination 
of morphologies, internal architecture, the interconnectivity of as-fabricated tissue 
scaffolds, and provides a quantitative measurement of porosity and micro-architecture. 
The pore size of scaffolds determined to be between 200 and 400 microns is the optimal 
size suggested for bone tissue scaffold application. In addition, strut width was found to 
be consistent between samples. A cell-scaffold interaction study demonstrated the 
biocompatibility of the process and material, and also suggested larger spaces for further 
investigation and improvement. An in vivo study suggested that there was increased 
osseous ingrowth for each time period of 4, 6 and 8 weeks, indicating that the osteoblast 
cells were able to attach and proliferate on the PCL scaffold. The homogenous dark pink 
areas within the stained slides were assumed to be pockets of bone matrix formation, due 
to the noticeable calcium deposits/bone formation seen in the corresponding radiographs.  
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5.10. Conclusion 
 
The ability to fabricate PCL scaffolds using the PED system was demonstrated. 
Results of the characterization demonstrated the accuracy of PED fabrication of 
controlled microstructure and pore size. Success in scaffold-guided tissue engineering 
requires a greater understanding of the cellular response to the constructed micro 
environment. PED has the advantage of high precision on the micro-scale as well as 
repeatability not amenable with more traditional scaffold manufacturing methods. This 
process opens opportunities for complex scaffold fabrication. A cell-scaffold interaction 
study demonstrated the biocompatibility of the process and material. No adverse 
cytotoxic effects were observed with these scaffolds. Success in scaffold guided tissue 
engineering requires a good understanding of the cellular response to the constructed 
microenvironment. With this technique, scaffolds with complex internal geometries can 
be studied with the ultimate goal of generating structures optimized for bone tissue 
ingrowth. 
 
5.11. Acknowledgments 
 
I would like to acknowledge NSF for funding of this project. I would like to thank Dr. 
Yuehuei An and Jennifer Gordon of the Medical University of South Carolina. The In-
vivo work was conducted at MUSC under the supervision of Dr.An. I would also like to 
thank Dr. Ko and Dr. Milind Ghandi of Drexel University for assistance with the 
Biological experiments.  
 
 
 
58 
 
6. POLYCAPROLACTONE/ HYDROXYAPATITE TISSUE 
SCAFFOLDS 
 
Because of the advances in the scaffolds fabrication techniques bone tissue engineering 
is increasingly becoming a method of choice for the development of viable substitutes 
for skeletal reconstruction. Material used for fabricating scaffolds for bone tissue 
engineering application should have the mechanical integrity sufficient enough for bone 
cells to attach, proliferate and differentiate in a manner similar to native ECM. 
Polycaprolactone (PCL) has been used by many for such an application because of its 
biodegradable and biocompatible properties[35, 102] . PCL is a semi-crystalline 
aliphatic polymer that has a slower degradation rate than most biopolymers in its homo-
polymeric form. It has a low glass transition temperature at -60ºC, a melting temperature 
at about 58ºC - 60ºC, and a high thermal stability. It has a high decomposition 
temperature of 350ºC. The mechanical properties of bulk PCL (Mw = 44,000) with a 
tensile strength of 16 MPa, tensile modulus of 400 MPa, flexural modulus of 500 MPa, 
elongation at yield of 7%, and elongation at break of 80% have been reported [14-19]. 
Bone is a composite structure made up of mineral, matrix, cells, and water. Chemically 
bone is made up of 58% calcium phosphate, 7% calcium carbonate, 1-2% calcium 
fluoride, 1-2% magnesium phosphate and 1% sodium chloride. These minerals together 
form a crystal called hydroxyapatite (HA). The chemical constituent of HA is 
[Ca10(PO4)6(OH)2]. Remaining part of bone is made up of water, cells and ECM [20]. 
Commercially available HA has been widely investigated for bone tissue engineering 
applications [ 35]. It is both mechanically strong and osteoconductive. However, 
because of its brittle characteristic and material properties, it is often difficult to process. 
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We fabricated PCL and PCL-HA composite scaffolds, having 25% HA by weight using 
PED system. The pore size and porosity were optimized by varying the diameter of the 
nozzle tip. Scanning Electron Microscopy (SEM) was used to characterize the 
morphologies and microstructures of the PED fabricated scaffolds. Instron 5800R was 
used to calculate mechanical property of scaffolds. The cell-scaffold interaction was 
studied using primary fetal bovine osteoblasts. 
 
6.1. Fabrication 
 
PCL (Sigma Aldrich Inc, Milwaukee, Wisconsin) in the form of pellets was used as the 
scaffolding material. Hydroxyapatite (Clarkson Chromatography Products Inc, South 
Williamsport, PA) in a form of a powder, with particles ranging in size from 10-25 
microns, were melt blended with PCL, for the fabrication of composite scaffold. Two 
concentrations were blended, 25% by weight HA and 50% by weight HA. First to mix 
the composite the appropriate amount of PCL was measured and poured into a glass 
flask and placed in an oven for 30min at 90 degrees Celsius.  Subsequently the 
appropriate amount of HA powder was weight and poured into the flask immediately 
after removal from the oven. While the viscosity was sufficiently low, a spatula was 
used to mix the composite by hand. The mixture was then reheated for 10 min and then 
mixed again.  
PED system developed at Drexel University was used for manufacturing scaffolds. The 
mini-extruder system deliveries the PCL or PCL-HA in a fused form through the 
deposition nozzle. The material is fused by a liquefier temperature provided by two 
heating bands and respective thermal couples. PCL or PCL-HA is then extruded due to 
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pressure created by turning precision screw. Two sets of cylindrical scaffolds, measuring 
20mm in diameter, were fabricated with 450 micron roads, or width of the extruded 
material, and porosities of 60% and 70% respectively. The liquefier temperature was set 
to 90oC, and a .245 mm exit diameter nozzle was used. Each layer was filled with the 
designed scaffold pattern of a 0/90 degree orientation to generate the porous structure. 
6.2. Morphology Study by SEM 
 
 FEI/Phillips XL-30 Field Emission Environmental Scanning Electron Microscope 
was used to evaluate the bulk PCL-HA material and PCL-HA scaffolds. The SEM images 
were taken by using beam intensity at 20 kV and the gaseous secondary electron 
detectors at 1.3 Torr. 
 
Figure 39: SEM of Bulk PCL-HA material with Backscatter detection 
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Figure 40: High Resolution SEM of Bulk PCL-HA material with backbcatter detection 
 
The backscatter SEM images of melt blended PCL-HA (Figure 39) and as fabricated 
scaffold (Figure 41) were taken to examine the HA distribution in PCL. It shows uniform 
dispersion of HA particles with no visible areas of agglomeration. In addition, HA 
particles were seen protruding from the surface of the scaffold (Figure 42).  
 
 
Figure 41: SEM of PCL-HA scaffold with Back Scatter detection 
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Figure 42: SEM of PCL-HA structure with Backscatter detection 
 
Figure 43: SEM image of PCL-HA Scaffold 
 
The required architecture for tissue engineering scaffolds could be achieved at the 
micron scale level. The uniformity of the pores and the depositing roads shown 
demonstrate the applicability of using the PED process to fabricate composite scaffolds at 
micro-scale level.   
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Our characterization using backscatter SEM images suggested that there were no 
visible clumps of HA and it was distributed uniformly. It is important that the HA 
particles used for the reinforcement should be uniformly distributed in the PCL matrix to 
avoid the non-desirable stress transfer in the scaffolds. 
The feasibility of using PED process for freeform fabrication of PCL and PCL-HA 
scaffolds with designed pattern was investigated. In contrast to the conventional FDM 
process that requires use of pre-cursor filaments, the PED process directly extrudes 
scaffolding materials in its granulated form without the filament preparation step. This 
process is thus flexible, faster and continuous with virtually no interruptions for a variety 
of bio-polymer materials. The XYZ position system of the process can be used to 
precisely deposit the required material layer by layer with controlled architectures 
according to the design configuration.   
6.3.  Micro-CT Evaluation of HA distribution 
 
 
The SEM images only show the distribution HA on the top surface of the scaffold. To get 
better insight as to the distribution within the filament volume, Mico-CT scans were 
taken of a free extruded filament as well as of fabricated scaffolds. A SkyScan (Kontich, 
Belgium) 1172 micro-CT desktop scanner was used at 5.25 micron resolution.  Figure 44 
represents the cross section of a single filament strand of the PCL-HA composite material 
of 25% HA by weight. Since HA has a higher Hounsfield unit, a measure of radio 
density, value than PCL it appear brighter in the cross-sectional reconstruction as seen in 
Figure 44. 
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6.4.   Mechanical Properties of Scaffolds 
 
 Compression tests were conducted on both PCL and PCL-HA (25% concentration 
by weight) scaffolds. The Instron 5800R machine was used for evaluating compressive 
properties. The samples were 20 mm in diameter and 20 mm in height. Scaffolds of 60% 
and 70% porosity with pore sizes of 450 microns and 750 microns respectively were 
tested to determine the effect of porosity on mechanical properties. The tests were 
conducted with a cross-head displacement speed of 2 mm/min. Stress-Strain data was 
computed from Load-Displacement measurements and the compressive modulus was 
determined from the elastic region of the curve.  
 
Figure 48: Comparison of compressive properties of PCL and PCL-HA scaffolds 
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Material Porosity
Modulus 
(MPa)
PCL/HA 60%  84  
PCL  60%  59  
PCL/HA 70%  76  
PCL  70%  30  
 
Table 2: Compressive modulus of PCL and PCL-HA scaffolds 
 
 
The stress-strain curves derived from the testing data are plotted in Figure 48. The 
calculated compressive modulus from the stress-strain data are listed in Table 2: 
Compressive modulus of PCL and PCL-HA scaffolds. The results show that the less 
porous scaffolds had overall better properties.  
Inclusion of HA significantly improved the mechanical properties of PCL. Compressive 
modulus for 60% porous PCL scaffolds was 59 MPa and that of PCL-HA was 84 MPa 
whereas for 70% porous PCL scaffolds it was 30 MPa and for PCL-HA was 76 MPa . 
The porosity reduces the properties because of the lack of material in the scaffolds. The 
properties of composite scaffolds were similar to native properties of cancellous bone 
[20, 25] making them suitable for bone tissue scaffolds applications.  
 
6.5.   Initial cytotoxicity evaluation of Bulk PCL-HA material 
 
After melt blending the HA and PCL, it was nessesary to determine if the composite had 
any detrimental effects upon cell populations. Cells 7F2 cell were seeded on the top 
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surface of the 25% by weight PCL-HA bulk material as well as a control of polystyrene .  
Alamar Blue assay, a fluorometric indicator of cell metabolic activity, was performed to 
determine cell viability. They were washed with PBS after aspirating the medium. They 
were then re-fed with 1.8 ml of media and 0.2 ml of the Alamar Blue dye and allowed to 
incubate for 4 hours. The resulting 2 ml solution was removed from the sample and the 
fluorescence was measured at room temperature on a plate reader (GENios, TECAN, 
Durham, NC) using excitation and emission wavelengths of 520 nm and 590 nm, 
respectively. We see that the cells continue to proliferate over the entire 7 day culture 
period. This is an indication that the bulk material has no immediate cytotoxic effect. 
At the end of 7 days the bulk material was evaluated using a Live/Dead assay (Molecular 
Probes). The Live/Dead dye consists of calcein AM and ethidium homodimer (EthD-1) 
which react to membrane integrity and cytoplasmic esterases. Live cells appear green and 
dead appear red under the florescent microscope. 
 
 
Figure 49: Cell Viability over 7 days 
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Figure 50: Live Dead of PCL-HA 25% HA bulk material 
 
Figure 51: Live Dead of PCL-HA 50% HA bulk material 
 
6.6.   Cell Scaffold Interaction    
 
 Scaffold of size 14mm x 14mm x 3mm were seeded with primary fetal bovine 
osteoblast cells for a period of 21 days. The initial medium to maintain and proliferate the 
cells was prepared by mixing distilled H2O, 13.5 g of DMEM powder mix (sigma, cat 
#D7777), 0.0059 g Ascorbic Acid (sigma, cat #A0278), 0.0588 g Gentamicin (sigma, cat 
#G3632), 3.7 g Sodium Bicarbonate (sigma, cat #S5761), 3.905 g HEPES Buffer (sigma, 
cat #H0763), and, 20 ml Antibiotic/Antimycotic solution (sigma, cat #A9909) into 1 liter 
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volume. The medium was then filtered through a 0.22 µm filter into sterilized bottles. 88 
ml of FBS (sigma, cat #F2442) and 0.71 ml of 100X ITS (sigma, #I1884) per 500 ml 
medium were then added. For mineralization, 0.0783 g Calcium Chloride (sigma, cat 
#C7902), and 2.54 g beta-glycerol-phosphate (sigma, cat #G9891) supplements were 
added before filtering. The scaffolds were submerged in 70% ethanol for sterility and 
allowed to dry overnight. They were then washed with phosphate buffered saline (PBS) 
and were soaked in 2 ml of medium for 1 hour.  Approximately 1.5 x 106 cells were 
seeded onto each scaffold. The cell scaffold constructs were maintained in culture for 21 
days.  
6.6.1. Cell Viability and Proliferation 
 
Alamar Blue assay, a flurometric indicator of cell metabolic activity, was 
performed to determine cell viability and proliferation. The cell scaffold constructs were 
removed out of the culture plates on 3, 7, 11, 14 and 21 days. They were washed with 
PBS after aspirating the medium. They were then refed with 1.8 ml of medium and 0.2 
ml of the Alamar Blue dye and allowed to incubate for 4 hours. The resulting 2 ml 
solution was removed from the sample and the fluorescence was measured at room 
temperature on a plate reader (GENios, TECAN) using an excitation and emission 
wavelength of 520 nm and 590 nm respectively. A cell number was obtained through a 
calibration curve determined by correlating a known cell number with the fluorescent 
intensity of the solution. 
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Figure 52: Cell Viability over 21 days 
 
 
Figure 53: Alamar Blue calibration of cell number 
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The cells did proliferate and their number increased over time until day 11 
representing an active proliferation period. Figure 5 shows the results of Alamar Blue 
assay. The data is presented as the average of the 4 samples ± standard deviation. There 
was a statistically significant difference (P <0.05) in the cell numbers over the cultured 
time. However, there was no difference in the number of cells between PCL and PCL-
HA. A slight decline was experienced between day 11 and 14. The decline in cell 
population could be due to the inability of Alamar Blue to react with cells trapped within 
the mineralization matrix after day 11 and/or due to slowing of cell proliferation as they 
migrate through the depth of the scaffold where nutrients are not as readily available. The 
increase between day 14 and 21 may only indicate the active proliferation above the 
mineralization matrix and areas of the scaffold where calcification is less dense. 
6.6.2. Alkaline Phosphatase Activity  
 
 Samples were removed of medium and washed twice with a buffer solution on 7, 
14 and 21 days. The scaffolds were then submerged into 1 ml of 1% Triton x100 solution 
for cell lysis. They were then centrifuged and the supernatant was used to calculate 
alkaline phosphatase (ALP) activity by p-nitro phenyl phosphate (p-NPP) method. 
Alkaline phosphatase catalyzes the cleavage of p-NPP to give p-Nitrophenol and 
orthophosphate which develops a yellow color in the presence of a base. 0.5 ml of 
supernatant and 0.5 ml of diluted p-NPP (100μl of p-NPP concentrate per 2 ml of 100 
mM sodium bicarbonate/carbonate buffer, pH 10) were mixed and incubated for 45 mins. 
The absorbance of this mixture was read at 405 nm. The absorbance was converted to the 
units of alkaline phosphatase per liter. 
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(ml)volumeSampleX 18.8
X1000 (ml)volumeAssay X/minAbsorbance(U/L)ephosphatasAlkaline =                     
Absorbance/min = Absorbance/45 
Assay volume = 0.5+0.5 = 1ml 
Sample volume= 0.5ml 
18.8 = absorbance coefficient of pNPP 
 
 
Figure 54: Alkaline Phospatase Activity 
 
As seen from Figure 54 an upregulation of alkaline phosphatase through out the 
cultured time was observed, with the greatest increase within the first 14 days. PCL-HA 
scaffolds had higher ALP activity compared to PCL.  
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6.7. Cell Morphology by SEM 
 
The cell-scaffold constructs were removed from the culture media after 21 days. 
They were washed twice with 1x PBS and then fixed with 4% glutaraldehyde for 2 hrs. 
The constructs were then subjected to serial dilution of ethanol (20%, 50%, 70%, 90%, 
100%), each for 10 minutes for dehydration. They were refrigerated overnight at 4°C. 
The scaffolds were then coated with platinum and observed under SEM. 
The osteoblasts proliferation results in the formation of mineralized matrix. This 
was evident from the SEM images after 21 days (Figure 63, Figure 64). The SEM images 
proved that PCL-HA scaffolds produced more mineralized matrix compared to PCL 
scaffolds (Figure 56, Figure 59). Moreover, the matrix was seen oriented along the pores 
making circular regions (Figure 60) similar to natural bone’s Haversian systems [13, 27]. 
These results demonstrated that the osteoblasts had improved differentiation on PCL-HA 
scaffolds compared to PCL. 
 
Figure 55: Day 14 SEM image of PCL scaffold - top surface pore at 120x 
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Figure 56: Day 14 SEM image of PCL scaffold - top surface at 50x 
 
Figure 57: Day 14 SEM image of PCL scaffold - bottom surface 
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Figure 58: Day 14 SEM image of PCL scaffold - bottom surface pore 
 
 
 
 
Figure 59: Day 14 SEM image of PCL-HA scaffold - top surface 
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Figure 60: Day 14 SEM image of PCL-HA scaffold - top surface pore 
 
 
 
 
Figure 61: Day 14 SEM image of PCL-HA scaffold - bottom surface 
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Figure 62: Day 14 SEM image of PCL scaffold - bottom surface 200x 
 
 
 
 
Figure 63: Day 21 SEM image of PCL  scaffold - top surface 
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Figure 64: Day 21 SEM image of PCL-HA scaffold - top surface 
 
6.8.      Statistical Analysis 
 
  The statistical significance was determined by analysis of variance (ANOVA) and 
Tukey post-hoc test  at the significance level of less than 0.05 (P <0.05) using SPSS® 
version 14 for Windows® software package. 
 
6.9. Section Conclusion 
  
 Polycaprolactone is a biodegradable and biocompatible polymer with slow 
degradation rate adequate for bone tissue engineering applications. The surface 
hydrophobicity works against PCL when it comes to cell attachment [22-24]. HA is 
natural ceramic material found in the bones. We studied a composite material by melt 
blending PCL and HA to improve both mechanical and surface properties of the 
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composite PCL-HA tissue scaffolds. In the reported study, 25% HA by weight was used 
to reinforce PCL. 60% and 70% porous scaffolds with 100% interconnectivity and pore 
size of 450 microns and 750 microns respectively were fabricated after optimizing the 
processing parameters of PED system.  
 The cell-matrix interaction was carried out using fetal bovine osteoblasts. There was 
no statistical difference in cell proliferation between PCL and PCL-HA (Figure 5). 
Alamar Blue assay was carried out for determining cell proliferation. It is a non-
destructive assay wherein the dye Alamar Blue detects the metabolic activity of the cells. 
The cell numbers declined a bit on day 11 and 14 (Figure 53). We believe that this might 
be due to inability of dye to penetrate the scaffolds and react with the cells in the interior 
of scaffolds. This highly calcified matrix might have hindered Alamar Blue dye to go 
through the scaffolds. To demonstrate this we carried out a destructive assay for 
determining ALP activity using p-NPP method. The cell-scaffolds constructs were 
disrupted and cell lysis was prepared to perform the test. This allowed us to determine 
ALP from the cells without having any interference from the mineralized matrix 
surrounding the scaffolds. ALP is an enzyme produced by differentiating osteoblasts and 
is responsible for construction of bone matrix. A steady increase in the ALP activity was 
observed and the PCL-HA scaffolds had significantly higher ALP activity than PCL 
scaffolds (Figure 54).  
The ability to fabricate scaffolds of composite biomaterials using the PED system has 
been demonstrated. The scaffolds with controlled internal architectures were produced 
after optimizing the processing parameters. Results of the characterization demonstrated 
the capability of the PED fabrication process in manufacturing the scaffolds with 
 
 
81 
 
controlled microstructure and pore size. The scaffolds were 60%-70% porous with 100% 
interconnectivity. Success in scaffold guided tissue engineering requires a greater 
understanding of the cellular response to the constructed micro environment. PED has the 
advantage of high precision on the micro scale as well as repeatability not available using 
more traditional scaffold manufacturing methods. This process opens opportunities for 
complex scaffold fabrication. Scaffolds of 60% and 70% porosity with pore sizes of 450 
microns and 750 microns respectively were tested for their compressive properties. The 
composite PCL-HA scaffolds had significantly higher compressive modulus compared to 
PCL scaffolds. Cell-scaffolds interaction study demonstrated the biocompatibility of the 
process and material proving that the fabrication process has no adverse cytotoxic effect 
on the scaffolds. The PCL-HA composite scaffolds had higher expression on ALP 
activity and showed more mineralization of matrix compared to PCL. 
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7. CONCLUSION AND DISCUSSION 
 
A novel Solid Freeform Fabrication technique was developed called Precision Extrusion 
Deposition. It is a layered manufacturing system where a 3 dimensional object is created 
by stacking 2 dimensional layers that are directly extrude on the previous layer. The 
layers are created through an extrusion process. A screw extruder is mounted on a x-y-z 
positioning system, the synchronization of two creates the 2-D profile. A heating 
element, incorporated with the extruder, liquefies thermoplastic material allowing the 
molten material to be carried by the screw through the exit nozzle. This process of 
fabrication enables the creation of complex micro architectures directly formable from a 
computer STL Model.  
 
The feasibility of using PED process for freeform fabrication of PCL and PCL-HA 
scaffolds with designed pattern was investigated. In contrast to the conventional FDM 
process that requires use of pre-cursor filaments, the PED process directly extrudes 
scaffolding materials in its granulated form without the filament preparation step. This 
process is thus flexible, faster and continuous with virtually no interruptions for a variety 
of bio-polymer materials. The XYZ position system of the process can be used to 
precisely deposit the required material layer by layer with controlled architectures 
according to the design configuration.   
 Polycaprolactone is a biodegradable and biocompatible polymer with slow 
degradation rate adequate for bone tissue engineering applications. The surface 
hydrophobicity works against PCL when it comes to cell attachment [22-24]. HA is 
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natural ceramic material found in the bones. We studied a composite material by melt 
blending PCL and HA to improve both mechanical and surface properties of the 
composite PCL-HA tissue scaffolds. In the reported study, 25% HA by weight was used 
to reinforce PCL. 60% and 70% porous scaffolds with 100% interconnectivity and pore 
size of 450 microns and 750 microns respectively were fabricated after optimizing the 
processing parameters of PED system.  
 For fabrication of PCL-HA scaffolds PCL and HA were melt blended together to 
prepare a composite material. Our characterization using backscatter SEM images 
(Figure 3) suggested that there were no visible clumps of HA and it was distributed 
uniformly. It is important that the HA particles used for the reinforcement should be 
uniformly distributed in the PCL matrix to avoid the non-desirable stress transfer in the 
scaffolds. Inclusion of HA significantly improved the mechanical properties of PCL. 
Compressive modulus for 60% porous PCL scaffolds was 59 MPa and that of PCL-HA 
was 84 MPa whereas for 70% porous PCL scaffolds it was 30 MPa and for PCL-HA was 
76 MPa (Table 1). The porosity reduces the properties because of the lack of material in 
the scaffolds. The properties of composite scaffolds were similar to native properties of 
cancellous bone [20, 25] making them suitable for bone tissue scaffolds applications.  
 The cell-matrix interaction was carried out using fetal bovine osteoblasts. There was 
no statistical difference in cell proliferation between PCL and PCL-HA . Alamar Blue 
assay was carried out for determining cell proliferation. It is a non-destructive assay 
wherein the dye Alamar Blue detects the metabolic activity of the cells. The cell numbers 
declined a bit on day 11 and 14. We believe that this might be due to inability of dye to 
penetrate the scaffolds and react with the cells in the interior of scaffolds. The osteoblasts 
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proliferation results in the formation of mineralized matrix. This was evident from the 
SEM images after 21 days. This highly calcified matrix might have hindered Alamar 
Blue dye to go through the scaffolds. To demonstrate this we carried out a destructive 
assay for determining ALP activity using p-NPP method. The cell-scaffolds constructs 
were disrupted and cell lysis was prepared to perform the test. This allowed us to 
determine ALP from the cells without having any interference from the mineralized 
matrix surrounding the scaffolds. ALP is an enzyme produced by differentiating 
osteoblasts and is responsible for construction of bone matrix. A steady increase in the 
ALP activity was observed and the PCL-HA scaffolds had significantly higher ALP 
activity than PCL scaffolds (Figure 6). The SEM images proved that PCL-HA scaffolds 
produced more mineralized matrix compared to PCL scaffolds . Moreover, the matrix 
was seen oriented along the pores making circular regions similar to natural bone’s 
Haversian systems [20]. These results demonstrated that the osteoblasts had improved 
differentiation on PCL-HA scaffolds compared to PCL..  
7.1.  Conclusion 
 
 
The newly developed PED system is capable of producing repeatable structures with 
solid mechanical integrity. The capabilities of the system lend itself well to the field of 
scaffold based tissue engineering where a controlled micro-architecture is desired. The 
ability to fabricate scaffolds of composite biomaterials using the PED system has been 
demonstrated. The scaffolds with controlled internal architectures were produced after 
optimizing the processing parameters. Results of the characterization demonstrated the 
capability of the PED fabrication process in manufacturing the scaffolds with controlled 
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microstructure and pore size. The scaffolds were 60%-70% porous with 100% 
interconnectivity. Success in scaffold guided tissue engineering requires a greater 
understanding of the cellular response to the constructed micro environment. PED has the 
advantage of high precision on the micro scale as well as repeatability not available using 
more traditional scaffold manufacturing methods. This process opens opportunities for 
complex scaffold fabrication. Scaffolds of 60% and 70% porosity with pore sizes of 450 
microns and 750 microns respectively were tested for their compressive properties. The 
composite PCL-HA scaffolds had significantly higher compressive modulus compared to 
PCL scaffolds. Cellular biological studies and cell survivability studies were conducted 
and showed biocompatibility and promise for applications in orthopeadic tissue 
engineering. 
  
 
 
86 
 
 
8. FUTURE RECOMMENDATION 
 
8.1. Alternative applications for PED  
 
While the bulk of the research conducted with the PED sytem had been for tissue 
engineering applications, the layered manufacturing process is capable of fabrication 
parts using a variety of thermoplastic material.  
 
Poly(vinylidenefluoride) (PVDF): 
 
PVDF is of interest for it mechanical, optical, and electrical properties. There is growing 
interest in using PVDF or PVDF/ nano-tube composites as functional material[1]. These 
materials could have specific conductive properties with a high degree of flexibility and 
strength. With precision fabrication micro sized sensor or actuator could be achieved. 
Preliminary work has been conducted where PDVF filaments were created using the PED 
system, however, complex objects have not been attempted. Figure 65 shows the free 
extrusion of PVDF. 
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Figure 65: Free extrusion of PVDF 
 
 
PZT/ECG9 
 
PZT is a piezoelectric material of interest for sensor and actuator applications. ECG9 is a 
proprietary binder material developed at Rutgers as the primary binder material for the 
PZT particles investigated [ 2, 7,91,93]. Investigations into the adaptation of the 
commercial FDM system to produce PZT sensors has yielded mixed results. The 
aforementioned filament fabrication and buckling problem poses a limiting factor when 
producing the PZT green body part. After fabrication the part must go through a 
sintering/ binder burn out process, therefore the binder to particle ratio is important in 
limiting any void space to maintain part integrity [92]. The precursor filament process 
limits the particle volume fraction to maintain filament integrity and prevent buckling. 
With the PED a higher concentration of PZT can be attempted. The initial 
parameterization of the PED system include the fabrication of PZT/ECG9 parts as seen in 
Figure 12 and Figure 14. 
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Poly-β-hydroxybutyrate (PHB:) 
 
PHB is a naturally accruing biodegradable biomaterial. It can be synthesize in-vivo from 
bacteria at higher quantities than found in nature [66].   
This material is melt processable and has been proposed for use as absorbable suture. 
Preliminary work was conducted, and a scaffold structure was successfully created, 
however the effects of the thermal processing of the PED system has yet to be studied. 
 
 
 
Figure 66: PHB Scaffold 
 
8.2. Effects of architecture on cellular response in a perfusion flow 
environment  
 
Thus far, the manufacturability of scaffolds by means of PED has been proven. The next 
step is to determine the influence of architectural variations of our designed scaffold on 
cell proliferation and ECM generation. Native tissue does not have a homogenous 
structure [13,27]. In order to temporally control tissue in-growth, a heterogeneous 
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scaffold design may be required. Research has been conducted to determine optimal pore 
size and porosity for scaffold designed for hard tissue, using structure built from the 
traditional chemical methods. However those approaches to fabrication result in 
structures of random internal architecture. Our initial design included pores that were 
continuous and linear in the z-direction, unlike the tortuous path found in scaffold 
produced by chemical methods. Therefore, the 300-500 micro pore size and  60%-80% 
porosity, determine previously as optimal[103], may not be relevant in our type of 
structure. Due to the repeatability of the PED process, a more thorough investigation into 
the influence of the internal micro-architecture on cellular responses is available.    
Profusion flow experiments could be conducted to determine the influencing factors 
involved in heterogeneous scaffold architecture. The scaffold are easily modeled 
allowing for computational flow models as well as mechanical FEA analysis which could 
provide valuable information on the mechanism of tissue growth and integration.  
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Appendix: Configuration file for the x-y-z drivers.  
 
;Gemini GV Servo Drive Setup 
 
;Motor Setup 
DMTR 1304  ;Motor ID (SM/SE232AE) 
DMTIC 1.88  ;Continuous Current (Amps-RMS) 
DMTICD 12.40  ;Continuous Current Derating (% derating at rated 
speed) 
DMTKE 32.5  ;Motor Ke (Volts (0-to-peak)/krpm) 
DMTRES 7.50  ;Motor Winding Resistance (Ohm) 
DMTJ 92.650  ;Motor Rotor Inertia (kg*m*m*10e-6) 
DPOLE 2  ;Number of Motor Pole Pairs 
DMTW 75.0  ;Motor Rated Speed (rev/sec) 
DMTIP 5.64  ;Peak Current (Amps-RMS) 
DMTLMN 3.4  ;Minimum Motor Inductance (mH) 
DMTLMX 4.7  ;Maximum Motor Inductance (mH) 
DMTD 0.000024 ;Motor Damping (Nm/rad/sec) 
DMTRWC 0.51  ;Motor Thermal Resistance (degrees Celsius/Watt) 
DMTTCM 21.7  ;Motor Thermal Time Constant (minutes) 
DMTTCW 0.33  ;Motor Winding Time Constant (minutes) 
DMTAMB 40.00 ;Motor Ambient Temperature (degrees Celsius) 
DMTMAX 125.00 ;Maximum Motor Winding Temperature (degrees Celsius) 
 
;Drive Setup 
DMODE 2  ;Drive Control Mode 
DRES 4000  ;Drive Resolution (counts/rev) 
DPWM 0  ;Drive PWM Frequency (kHz) 
SFB 1   ;Encoder Feedback 
ERES 4000  ;Encoder Resolution (counts/rev) 
ORES 4000  ;Encoder Output Resolution (counts/rev) 
DMEPIT 0.00  ;Electrical Pitch (mm) 
SHALL 0  ;Invert Hall Sensors 
DMTLIM 2.1  ;Torque Limit (Nm) 
DMTSCL 2.1  ;Torque Scaling (Nm) 
DMVLIM 96.000000 ;Velocity Limit (rev/sec) 
DMVSCL 96.000000 ;Velocity Scaling (rev/sec) 
 
;Load Setup 
LJRAT 0.0  ;Load-to-Rotor Inertia Ratio 
LDAMP 0.0000 ;Load Damping (Nm/rad/sec) 
 
;Fault Setup 
FLTSTP 1  ;Fault on Startup Indexer Pulses Enable 
FLTDSB 1  ;Fault on Drive Disable Enable 
SMPER 4000  ;Maximum Allowable Position Error (counts) 
SMVER 0.000000 ;Maximum Allowable Velocity Error (rev/sec) 
DIFOLD 0  ;Current Foldback Enable 
 
;Digital Input Setup 
 
 
d 
 
INLVL 11000000 ;Input Active Level 
INDEB 50  ;Input Debounce Time (milliseconds) 
LH 0   ;Hardware EOT Limits Enable 
 
;Digital Output Setup 
OUTLVL 0100000 ;Output Active Level 
 
;Analog Monitor Setup 
DMONAV 0  ;Analog Monitor A Variable 
DMONAS 100  ;Analog Monitor A Scaling (% of full scale output) 
DMONBV 0  ;Analog Monitor B Variable 
DMONBS 100  ;Analog Monitor B Scaling (% of full scale ouput) 
 
;Servo Tuning 
DIBW 1000  ;Current Loop Bandwidth (Hz) 
DVBW 100  ;Velocity Loop Bandwidth (Hz) 
DPBW 25.00  ;Position Loop Bandwidth (Hz) 
SGPSIG 1.000 ;Velocity/Position Bandwidth Ratio 
SGIRAT 1.000 ;Current Damping Ratio 
SGVRAT 1.000 ;Velocity Damping Ratio 
SGPRAT 1.000 ;Position Damping Ratio 
DNOTAF 0  ;Notch Filter A Frequency (Hz) 
DNOTAQ 1.0  ;Notch Filter A Quality Factor 
DNOTAD 0.0000 ;Notch Filter A Depth 
DNOTBF 0  ;Notch Filter B Frequency (Hz) 
DNOTBQ 1.0  ;Notch Filter B Quality Factor 
DNOTBD 0.0000 ;Notch Filter B Depth 
DNOTLG 0  ;Notch Lag Filter Break Frequency (Hz) 
DNOTLD 0  ;Notch Lead Filter Break Frequency (Hz) 
SGINTE 1  ;Integrator Enable 
 
SGP 15.000000,14.000000,8.800000,0.500000 
SGI 0.000000,0.000000,0.000000,0.000000 
SGILIM 0,0,0,0 
SGV 4.800000,4.900000,5.000000,0.000000 
SGVF 0.000000,0.000000,0.000000,0.000000 
SGAF 0.000000,0.000000,0.000000,0.000000 
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Appendix: Nozzle Schematic  
Units are in inches 
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Appendix: Typical Motion Planner Code for a Scaffold 
 
 
;Z=0.23 
V25.00,25.00,25.00:A2000.00,2000.00,2000.00: 
error1111:d,,-10.00:go,,1: 
 
d4.78,6.73:go11: 
DEF PG000: 
paxes1,2,,4:ppro8.00:pv10.00:pa1000.00:pad1000.00: 
pab1:pwc4.78,6.73:pl0: 
plin 6.78,4.70: 
plin 7.70,4.01: 
plin 8.71,3.38: 
plin 3.71,8.38: 
plin 2.84,9.86: 
plin 9.40,3.30: 
plin 10.08,3.00: 
plin 10.77,2.51: 
plin 2.97,10.31: 
plin 2.62,11.28: 
plin 11.00,2.90: 
plin 11.96,2.51: 
plin 2.79,11.68: 
plin 2.44,12.65: 
plin 12.40,2.69: 
plin 12.65,2.67: 
plin 13.08,2.62: 
plin 2.69,12.98: 
plin 2.77,13.51: 
plin 13.51,2.77: 
plin 14.05,2.84: 
plin 2.84,14.05: 
plin 2.92,14.58: 
plin 14.58,2.90: 
plin 15.11,2.97: 
plin 2.97,15.11: 
plin 3.00,15.27: 
plin 3.12,15.57: 
plin 15.57,3.12: 
plin 15.98,3.30: 
plin 3.30,15.98: 
plin 3.48,16.41: 
plin 16.41,3.48: 
plin 16.84,3.63: 
plin 3.63,16.81: 
plin 3.81,17.25: 
plin 17.25,3.81: 
plin 17.68,3.99: 
plin 3.99,17.68: 
plin 4.27,18.01: 
plin 18.01,4.27: 
plin 18.34,4.52: 
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plin 4.52,18.34: 
plin 4.78,18.69: 
plin 18.69,4.78: 
plin 19.02,5.03: 
plin 5.03,19.02: 
plin 5.31,19.35: 
plin 19.35,5.28: 
plin 19.68,5.56: 
plin 5.56,19.68: 
plin 5.89,19.96: 
plin 19.96,5.89: 
plin 20.22,6.22: 
plin 6.22,20.22: 
plin 6.58,20.47: 
plin 20.47,6.58: 
plin 20.73,6.91: 
plin 6.91,20.73: 
plin 7.24,21.01: 
plin 21.01,7.24: 
plin 21.26,7.59: 
plin 7.59,21.26: 
plin 8.00,21.44: 
plin 21.44,8.00: 
plin 21.62,8.43: 
plin 8.43,21.62: 
plin 8.84,21.79: 
plin 21.79,8.84: 
plin 21.97,9.27: 
plin 9.27,21.97: 
plin 9.70,22.15: 
plin 22.15,9.70: 
plin 22.25,9.98: 
plin 22.28,10.16: 
plin 10.13,22.28: 
plin 10.67,22.35: 
plin 22.35,10.67: 
plin 22.43,11.20: 
plin 11.23,22.40: 
plin 11.73,22.48: 
plin 22.48,11.73: 
plin 22.56,12.27: 
plin 12.19,22.63: 
plin 12.60,22.58: 
plin 12.88,22.56: 
plin 22.83,12.60: 
plin 22.45,13.56: 
plin 13.28,22.73: 
plin 14.25,22.38: 
plin 22.66,13.97: 
plin 22.28,14.94: 
plin 14.48,22.73: 
plin 15.16,22.25: 
plin 15.85,21.95: 
plin 22.40,15.42: 
 
 
h 
 
plin 21.54,16.89: 
plin 16.54,21.89: 
plin 17.55,21.26: 
plin 18.47,20.55: 
plin 20.50,18.52: 
END: 
pcomp PG000:d,,10.00:go,,1: 
prun PG000: 
d,,-10.00:go,,1: 
del PG000: 
 
EXIT: 
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